Live Breaking News & Updates on Mike Hencke

Stay updated with breaking news from Mike hencke. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ADDITIONAL DETAILED ANALYSES FROM PHASE 2 STUDY 201 OF LECANEMAB PUBLISHED AS THREE PAPERS IN PEER-REVIEWED JOURNALS

/PRNewswire/ Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge,. ....

United Kingdom , United States , New Zealand , Mike Hencke , Natacha Gassenbach , Christophera Viehbacher , Libby Holman , Haruo Naito , National Institute On , Communications Department , Alzheimer Research , Alzheimer Network Trials Unit , Eisai Europe Ltd , Ministry Of Health , Eisai Co Ltd , Prnewswire Eisai Co Ltd , European Medicines Agency , Advisory Committee , Investor Relations Department , Exchange Commission , Devices Agency , Biogen Inc , Public Relations Department , Eisai Inc , Washington University School Of Medicine , Drug Administration ,

Biogen Inc.: Additional Detailed Analyses From Phase 2 Study 201 of Lecanemab Published as Three Papers in Peer-Reviewed Journals

TOKYO and CAMBRIDGE, Mass., March 30, 2023 (GLOBE NEWSWIRE) Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts ....

United States , New Zealand , United Kingdom , Haruo Naito , Christophera Viehbacher , Libby Holman , Natacha Gassenbach , Mike Hencke , Washington University School Of Medicine , National Medical Products Administration , Exchange Commission , Communications Department , Drug Administration , Alzheimer Clinical Trial Consortium , Eisai Europe Ltd , Devices Agency , Eisai Co Ltd , National Institutes Of Health , Translational Research , Ministry Of Health , Alzheimer Network Trials Unit , Alzheimer Research , United Nations Sustainable Development Goals Sdgs , Public Relations Department , European Medicines Agency , National Institute On ,

EISAI PRESENTED NEW ANALYSES OF ARIA AND QOL ON LECANEMAB IN CLARITY AD AT THE AD/PD™ 2023 ANNUAL MEETING

/PRNewswire/ Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge,. ....

United Kingdom , New Zealand , United States , Libby Holman , Haruo Naito , Christophera Viehbacher , Natacha Gassenbach , Mike Hencke , Exchange Commission , Investor Relations Department , Advisory Committee , Prnewswire Eisai Co Ltd , European Medicines Agency , Ministry Of Health , Eisai Co Ltd , Eisai Europe Ltd , Communications Department , Alzheimer Network Trials Unit , International Conference On Alzheimer , National Institute On , United Nations Sustainable Development Goals Sdgs , Alzheimer Clinical Trial Consortium , National Institutes Of Health , Drug Administration , National Medical Products Administration , Washington University School Of Medicine ,

Additional Detailed Analyses From Phase 2 Study 201 of Lecanemab Published as Three Papers in Peer-Reviewed Journals

TOKYO and CAMBRIDGE, Mass., March 30, 2023 (GLOBE NEWSWIRE) Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB,… ....

United States , United Kingdom , New York , New Zealand , Natacha Gassenbach , Mike Hencke , Christophera Viehbacher , Libby Holman , Haruo Naito , Eisai Europe Ltd , Washington University School Of Medicine , Devices Agency , Biogen Inc , Investor Relations Department , Eisai Co Ltd , Alzheimer Network Trials Unit , Public Relations Department , Alzheimer Clinical Trial Consortium , Alzheimer Research , Eisai Inc , United Nations Sustainable Development Goals Sdgs , Ministry Of Health , National Medical Products Administration , Advisory Committee , Translational Research , National Institute On ,